The very core of every machine vision application is the software the performs the actual processing and analysis of the image. At this point specific software tools (“algorithms,” “operators,” etc. depending on the terminology used by the application or library vendor) are configured or programmed to perform specific analysis on the pixel-based data in the acquired image.
In terms of practical implementation, one construct for machine vision software can be described as an application that “configures” the system components and how they execute machine vision functions and tasks. These apps tend to have graphical user interfaces (GUI) devoted to “ease of use” with intuitive and graphically manipulated application configuration steps.
The successful application of machine vision technology involves an intricately and carefully balanced mix of a variety of elements. While the hardware components that perform the tasks of image formation, acquisition, component control, and interfacing are decidedly critical to the solution, machine vision software is the engine “under the hood” that supports and drives the imaging, processing, and ultimately the results.
British start-up Exscienta became the first company to put a AI-designed drug molecule to human trials earlier this year.
It took just 12 months for algorithms to create it, compared with four to five years for traditional research.
As coronavirus cases in Israel surge past 1,200, researchers in the country are predicting where it will spread next analyzing responses to questionnaires with AI.
After members of the public report their condition, algorithms evaluate their answers to connect symptoms to locations.